ArticleJournal of enzyme inhibition and medicinal chemistry2018

Structural re-positioning, in silico molecular modelling, oxidative degradation, and biological screening of linagliptin as adenosine 3 receptor (ADORA3) modulators targeting hepatocellular carcinoma.

Bassam M Ayoub et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.